𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Myth and reality: practical test system for the measurement of anti-DNA antibodies in the diagnosis of systemic lupus erythematosus (SLE)

✍ Scribed by Laura J. McCloskey; Paul Christner; Dana Jacobs-Kosmin; Troy D. Jaskowski; Harry R. Hill; Gabriella Lakos; Marius Teodorescu


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
164 KB
Volume
24
Category
Article
ISSN
0887-8013

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The myth persists that only the labor intensive Farr radioimmunoassay and Crithidia luciliae immunofluorescence (CL‐IFA) are systemic lupus erythematosus (SLE)‐specific tests. We compared them to ELISA with bacteriophage λ DNA (EL‐dsDNA) and denatured calf thymus DNA (EL‐ssDNA). By percentile ranking, the specificity cut‐off level was set both out of clinical context (SOCC) on 100 blood bank donors, and in clinical context (SICC) on 100 patients with either rheumatoid arthritis or scleroderma (50/50). Clinical sensitivity was calculated on 100 random SLE patients. At 95% SICC, the sensitivity of Farr, CL‐IFA, EL‐dsDNA, and EL‐ssDNA was similar (95%CI): 76% (66–84), 76% (66–84), 63% (53–72), and 75% (65–83), respectively; 87% of the patients were positive by at least one method and 55%by all methods. At 99% SICC, the sensitivity was also similar (95% CI): 57% (47–67), 47% (37–57), 58% (47–67), and 43% (33–53), respectively. The areas under ROC curve were similar (95% CI) when patients were used as controls for specificity. At 99% SOCC, EL‐ssDNA identified 89% positive, 2 negative but positive by another method at 95% SICC, and 9 negative (i.e. 89/2/9), followed by CL‐IFA (80/6/14), Farr (76/12/12), and EL‐dsDNA (64/23/13). Thus, at relatively low cost and easy automation, under the same conditions of specificity, the two ELISA tests combined were at least as good, if not superior, to CL‐IFA or Farr: they showed similar clinical sensitivity and also identified more patients with anti‐DNA antibodies. J. Clin. Lab. Anal. 24:77–84, 2010. © 2010 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Detection of cross-reactive anti-DNA ant
✍ Dr. D. A. Isenberg; Y. Shoenfeld; M. Walport; C. Mackworth-Young; C. Dudeney; A. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 757 KB

Two common cross-reacting anti-DNA antibody idiotypes designated 1616 and 32/15, previously identified in the serum of patients who have systemic lupus erythematosus, were found in 24% and 7%, respectively, of 147 first-degree relatives. These findings imply that high-frequency germ-line genes exist

DNA–ANTI-DNA Complexes account for part
✍ J. L. Subiza; A. Caturla; D. Pascual-Salcedo; M. J. Chamorro; E. Gazapo; M. A. F 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

We examined the effect of DNase treatment of sera with antihistone activity. In non-systemic lupus erythematosus (SLE) sera, antihistone levels remained unmodified, but a significant decrease was observed in 7 of 11 SLE sera with anti-DNA antibodies. This was accompanied in some by an increase in an